BioNTech SE (ETR:22UA)
101.70
+6.60 (6.94%)
At close: Aug 21, 2026
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
€339,439
Profits / Employee
€216,011
Market Cap
25.08B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Fresenius Medical Care AG | 107,226 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 62,136 |
| Fielmann Group AG | 18,928 |
| Sartorius Aktiengesellschaft | 14,279 |
| Ottobock SE & Co. KGaA | 10,365 |
BioNTech SE News
- 3 days ago - BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 - GlobeNewsWire
- 19 days ago - BioNTech SE Earnings Call Transcript: Q2 2026 - Transcripts
- 19 days ago - BioNTech SE Earnings release: Q2 2026 - Filings
- 19 days ago - BioNTech SE Slides: Q2 2026 - Filings
- 19 days ago - Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings - Barrons
- 19 days ago - BioNTech lowers 2026 sales outlook as COVID vaccine demand softens - Reuters
- 19 days ago - BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update - GlobeNewsWire
- 20 days ago - BioNTech says Sobi's Oelkers will replace Sahin as CEO - Reuters